@article{TLCR19341,
author = {Francesco Facchinetti and Luc Friboulet},
title = {Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {In the last decade huge improvements in prognosis
and quality of life have been provided by the molecular
characterization of non-small cell lung cancer (NSCLC).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/19341}
}